Format

Send to

Choose Destination
Int J Infect Dis. 2017 Oct;63:95-98. doi: 10.1016/j.ijid.2017.08.017. Epub 2017 Sep 6.

Candida auris: An emerging multidrug-resistant pathogen.

Author information

1
Division of Infectious Diseases, University of California, San Francisco, USA. Electronic address: david.sears@ucsf.edu.
2
Division of Infectious Diseases, University of California, San Francisco, USA.

Abstract

Candida aurisis an emerging multidrug-resistant pathogen that can be difficult to identify using traditional biochemical methods. C. auris is capable of causing invasive fungal infections, particularly among hospitalized patients with significant medical comorbidities. Echinocandins are the empiric drugs of choice for C. auris, although not all isolates are susceptible and resistance may develop on therapy. Nosocomial C. auris outbreaks have been reported in a number of countries and aggressive infection control measures are paramount to stopping transmission.

KEYWORDS:

Candida auris; Healthcare-associated; Infection control; Multidrug-resistance; Outbreak

PMID:
28888662
DOI:
10.1016/j.ijid.2017.08.017
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center